Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker
US7972612B2 · kind B2 · utility
2Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2003 |
| Grant date | Jul 5, 2011 |
| Priority date | — |
| Expiry date | Sep 8, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A subject of the present invention is to find utility of a combination of a Rho kinase inhibitor having a novel action and a β-blocker as a therapeutic agent for glaucoma. Actions of reducing intraocular pressure are complemented and/or enhanced each other by combining the Rho kinase inhibitor with the β-blocker. For the administration mode, each drug can be administered in combination or in mixture.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.